| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/15/2005 | EP1539817A1 Immunoassays for specific determination of scca isoforms |
| 06/15/2005 | EP1539813A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 06/15/2005 | EP1539811A2 Production of bispecific molecules using polyethylene glycol linkers |
| 06/15/2005 | EP1539805A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
| 06/15/2005 | EP1539793A2 Humanized anti-lymphotoyin beta receptor antibodies |
| 06/15/2005 | EP1539791A2 Method for distinguishing ulcerative colitis from crohn s di sease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca) |
| 06/15/2005 | EP1539785A2 Gene regulation in transgenic animals using a transposon-based vector |
| 06/15/2005 | EP1539247A2 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 06/15/2005 | EP1539238A2 Monoclonal antibodies and complementarity-determining regions binding to ebola glycoprotein |
| 06/15/2005 | EP1539237A2 Humanized antibodies against human 4-1bb |
| 06/15/2005 | EP1539236A2 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 06/15/2005 | EP1539235A2 Antibodies that specifically bind to reg iv |
| 06/15/2005 | EP1539234A1 Methods of preventing or treating cell malignancies by administering cd2 antagonists |
| 06/15/2005 | EP1539233A1 Super humanized antibodies |
| 06/15/2005 | EP1539228A2 Novel composition and methods for the treatment of immune related diseases |
| 06/15/2005 | EP1539221A2 Transferrin fusion protein libraries |
| 06/15/2005 | EP1539212A2 Methods and compositions for preventing oxidative degradation of proteins |
| 06/15/2005 | EP1539209A2 Compositions and methods for synthesizing nucleic acids |
| 06/15/2005 | EP1539200A2 Method for the treatment of multiple sclerosis |
| 06/15/2005 | EP1539199A2 Methods and compositions for in vivo clearance of pathogens |
| 06/15/2005 | EP1485129A4 Nanostructures containing pilin protein |
| 06/15/2005 | EP1309625B1 Therapeutic compounds for ovarian cancer |
| 06/15/2005 | EP1276496B1 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/15/2005 | EP1275000A4 Detection of erythropoietin and erythtropoietin receptor |
| 06/15/2005 | EP1261641A4 Diagnostic method using expression of mn/ca9 protein in agus pap smears |
| 06/15/2005 | EP1062348B1 Recombinant onconase and fusion proteins of recombinant onconase |
| 06/15/2005 | EP0998556B1 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1) |
| 06/15/2005 | EP0969866B1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 06/15/2005 | EP0955948B1 Induction of immunological tolerance |
| 06/15/2005 | EP0954602B1 Hereditary hemochromatosis gene |
| 06/15/2005 | EP0914344B1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 06/15/2005 | EP0815213B1 An immortalized mammal hybridoma fusion partner |
| 06/15/2005 | CN1628249A Paramycobacterial diagnostics and vaccines |
| 06/15/2005 | CN1628179A Gene and protein relating to hepatocellular carcinoma |
| 06/15/2005 | CN1628169A Artificial human chromosome containing human antibody lambda light chain gene |
| 06/15/2005 | CN1626669A Preparation of full-length human antibody |
| 06/15/2005 | CN1626655A Synthetase-1b for human cholesterol ester and coded sequence |
| 06/15/2005 | CN1626553A Monoclonal antibody for anti ligand of human apopain 2 |
| 06/15/2005 | CN1626552A Angiogenesis related molecules |
| 06/15/2005 | CN1626550A Excreted proteins as indicators related to tumor and application |
| 06/15/2005 | CN1626548A Protein purification by ion exchange chromatography |
| 06/15/2005 | CN1626547A Protein purification by ion exchange chromatography |
| 06/15/2005 | CN1626241A Proteins derived from white spot syndrome virus and uses thereof |
| 06/15/2005 | CN1206351C Preparing process and application of lysozyme protein |
| 06/15/2005 | CN1206243C Yolk antibody and antigen of pig's infective enterogastritis virus and its preparing process |
| 06/15/2005 | CN1206241C Novel natural antibacterial peptide, its code sequence and application |
| 06/14/2005 | US6906172 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 06/14/2005 | US6906034 Insulin like growth factor binding protein complex for use as wound healing agent in animals and humans |
| 06/14/2005 | US6906029 Insulin-like growth factor binding protein (IGFBP-5) |
| 06/14/2005 | US6905874 Contacting T-cells with a surface that has attached thereto one or more agents that ligate a cell surface moiety and applying a force that drives cell concentration and cell surface moiety ligation |
| 06/14/2005 | US6905855 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905687 Fusion proteins; immunogens; solid phase synthesis; kits |
| 06/14/2005 | US6905686 Active immunization for treatment of alzheimer's disease |
| 06/14/2005 | US6905685 Antiproliferative agents; monoclonal antibodies; blocking immunology response; autoimmune disease, antidiabetic agents, antiarthritic agents, antitumor, anticancer agents |
| 06/14/2005 | US6905684 Preventives and remedies for diffuse lung diseases |
| 06/14/2005 | US6905681 Methods for selectively stimulating proliferation of T cells |
| 06/14/2005 | US6905680 Induction of lymphocytes; obtain cells, activate cells, incubate with activator, monitor lymphocyte proliferation |
| 06/14/2005 | CA2308142C Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them |
| 06/14/2005 | CA2264585C Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions |
| 06/14/2005 | CA2162577C Human immunoglobulin vh gene segments and dna fragments containing the same |
| 06/10/2005 | CA2489266A1 Reagents for detecting efavirenz |
| 06/09/2005 | WO2005052169A2 Plant disease resistance and sar regulator protein |
| 06/09/2005 | WO2005052158A1 Anticarcinoma antibidies and uses thereof |
| 06/09/2005 | WO2005052157A1 Il-23 and its receptor; related reagents and methods |
| 06/09/2005 | WO2005052156A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 06/09/2005 | WO2005052126A2 Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (i) interferon producing cells |
| 06/09/2005 | WO2005052122A2 METHODS FOR CONTROLLING PATHOLOGICAL ANGIOGENESIS BY INHIBITION OF α6β4 INTEGRIN |
| 06/09/2005 | WO2005052007A1 Recombinant anti-cd64-immunotoxins |
| 06/09/2005 | WO2005052006A2 Mutated anti-cd22 antibodies and immunoconjugates |
| 06/09/2005 | WO2005052005A1 Anti-igfr1 antibody therapeutic combinations |
| 06/09/2005 | WO2005052004A2 Compositions comprising polypeptides |
| 06/09/2005 | WO2005052003A2 Use of antibodies to the gamma 2 chain of laminin 5 to inhibit tumor growth and metastasis |
| 06/09/2005 | WO2005052002A2 Single-domain antibodies and uses thereof |
| 06/09/2005 | WO2005052001A2 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation |
| 06/09/2005 | WO2005052000A2 Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| 06/09/2005 | WO2005051999A2 Substance binding human igg fc receptor iib |
| 06/09/2005 | WO2005051998A2 Antibodies binding to a c-terminal fragment of apolipoprotein e |
| 06/09/2005 | WO2005051994A2 Ztnf11, a tumor necrosis factor |
| 06/09/2005 | WO2005051993A1 Novel muscle growth regulator |
| 06/09/2005 | WO2005051983A2 Oligomeric complexe formation of recombinant multi subunit chimeric polypeptides |
| 06/09/2005 | WO2005051662A2 Methods for detecting l-ficolin dependent activation of the lectin pathway of complement and kits therefor |
| 06/09/2005 | WO2005051424A1 Targeting of erb antigens |
| 06/09/2005 | WO2005051423A2 Methods and agents for immune modulation and methods for identifying immune modulators |
| 06/09/2005 | WO2005051422A1 Method for the treatment of multiple sclerosis by inhibiting il-17 activity |
| 06/09/2005 | WO2005051355A1 Solid forms of anti-egfr-antibodies |
| 06/09/2005 | WO2005051321A2 Treatment of inflammatory bowel disease through induction of indoleamine 2,3-dioxygenase |
| 06/09/2005 | WO2005051307A2 Epha2 agonistic monoclonal antibodies and methods of use thereof |
| 06/09/2005 | WO2005051299A2 Metalloproteinase-binding proteins |
| 06/09/2005 | WO2005051295A2 Asymmetrically branched polymer conjugates and microarray assays |
| 06/09/2005 | WO2005051289A2 Homogeneous preparations of chimeric proteins |
| 06/09/2005 | WO2005051178A2 Marker for neuromyelitis optica |
| 06/09/2005 | WO2005042774A3 Method for linking sequences of interest |
| 06/09/2005 | WO2005030939A3 Method and composition for regulating expansion of stem cells |
| 06/09/2005 | WO2005028499A3 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 06/09/2005 | WO2005023201A3 Methods for treating rheumatoid arthritis |
| 06/09/2005 | WO2005023177A3 Human monoclonal antibodies against bacillusanthracis protective antigen |
| 06/09/2005 | WO2005021728A3 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations |
| 06/09/2005 | WO2005019470A3 Detecting and profiling molecular complexes |
| 06/09/2005 | WO2005014039A3 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative diseases |